Randomised, Evaluator-Blinded, Multicentre, International, Parallel-Group, Active-Controlled Clinical Trial of Gusperimus Versus Conventional Therapy in Relapse of Granulomatosis With Polyangiitis (Wegener's Granulomatosis) SPARROW Study - SPAnidin in Relapsing GRanulomatosis With POlyangiitis Wegener's Granulomatosis)

Trial Profile

Randomised, Evaluator-Blinded, Multicentre, International, Parallel-Group, Active-Controlled Clinical Trial of Gusperimus Versus Conventional Therapy in Relapse of Granulomatosis With Polyangiitis (Wegener's Granulomatosis) SPARROW Study - SPAnidin in Relapsing GRanulomatosis With POlyangiitis Wegener's Granulomatosis)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2015

At a glance

  • Drugs Gusperimus (Primary) ; Azathioprine; Cyclophosphamide; Glucocorticoids; Methotrexate
  • Indications Wegener's granulomatosis
  • Focus Registrational; Therapeutic Use
  • Acronyms SPARROW
  • Sponsors Nordic Drugs
  • Most Recent Events

    • 21 Jan 2015 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
    • 30 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top